Learn More
Medchemexpress LLC Avotaciclib trihydrochloride | 1983984-01-5 | 99.6% | 390.66 g/mol | C13H14Cl3N7O | 5 MG

Supplier: Medchemexpress LLC HY137432A5MG
Avotaciclib trihydrochloride is an orally active cyclin-dependent kinase 1 (CDK1) inhibitor provided as a research reagent for preclinical cancer studies. It inhibits tumor cell proliferation and induces apoptosis in multiple tumor cell lines and is supplied as the trihydrochloride salt.
- Orally active CDK1 inhibitor for preclinical research.
- Useful in studies of lung and pancreatic cancer cell lines.
- Trihydrochloride salt form for enhanced solubility.
- High purity (99.6% by HPLC).
- Molecular weight 390.66 g/mol; formula C13H14Cl3N7O.
- Supplied as a 5 mg research-grade sample.
- For research use only; not for human consumption.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.